The findings surprised several researchers because Helicobacter pylori infections are a major risk factor for gastric cancers, but people with H. pylori infections seldom develop Barrett’s Esophagus.
Researchers analyzed endoscopy data for 108 patients with non-cardia gastric cancers at New York City-based Mount Sinai Hospital.
Nine patients had a confirmed Barrett’s Esophagus diagnosis.
Here’s what they found.
1. Seven of the patients with Barrett’s had stage zero or stage one cancer, compared with 40 percent of those without Barrett’s.
2. None of the patients with Barrett’s developed dysplasia or adenocarcinoma.
3. Overall, 7.4 percent of patients had H. pylori infections.
Researchers found no links between H. pylori and the presence or absence of Barrett’s, despite the two diseases having an “unclear relationship.”
The researchers disclosed the study did not identify upper endoscopies however.
Researchers concluded that a relationship exists between the two diseases, and said the findings warrant further study.
More articles on gastroenterology:
4 GI devices receive FDA clearance in January 2017
GI leader to know: Dr. David Freeto of Queen of the Valley Medical Center
ArQule’s, Daiichi Sankyo’s hepatocellular carcinoma drug fails to improve survival in HCC patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.